Mert Erkan

The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma

Mert Erkan, Christoph Michalski, Simon Rieder et al. · Clinical Gastroenterology and Hepatology · 2008 · 414 citations

Tumor Biology, Activated Stroma Index, Pancreatic Cancer +9

StellaTUM: current consensus and discussion on pancreatic stellate cell research

Mert Erkan, Guido Adler, Minoti V. Apte et al. · Gut · 2011 · 414 citations · Full text

Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

Paweł K. Mazur, Alexander Herner, Stephano S. Mello et al. · Nature Medicine · 2015 · 401 citations · Full text

Histone Modifications, Chromatin, Tumor Biology +12

Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase

Dietrich Alexander Ruess, Guus J.J.E. Heynen, Katrin J. Ciecielski et al. · Nature Medicine · 2018 · 363 citations

Tumor Biology, Mutant Kras-driven Cancers, Cancer Cell Biology +4

Periostin Creates a Tumor-Supportive Microenvironment in the Pancreas by Sustaining Fibrogenic Stellate Cell Activity

Mert Erkan, Jörg Kleeff, Andre Gorbachevski et al. · Gastroenterology · 2007 · 296 citations

Fibrosis, Tumor-supportive Microenvironment, Pancreatic Cancer +9